Showing 1 posts of 1 posts found.
Hansa Biopharma, a commercial-stage biopharmaceutical company focusing on rare immunological conditions, has announced the appointment of Max Sakkajja as Vice …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO